Project

Innovative Nucleic Acids Technologies for Analysis, Detection and Treatment

Years
0
Partners
0
Countries
0
Research areas
0
Doctoral candidates
0

Objectives

The overarching goal of INT2ACT is to contribute to the field of nucleic acid therapeutics for personalised medicine by advancing current methodologies for the detection (WP1) and sequencing (WP2), synthesis and analysis (WP3), and target identification and delivery (WP4) of nucleic acids, while training 15 highly qualified researchers (WP5). To reach the project’s goal the following objectives have been stablished:

Develop more sensitive and accurate NAs detection methods for disease markers in liquid biopsies by identifying new RNA-based biomarkers for therapy toxicity and treatment efficacy, developing machine learning (ML) algorithms for faster analysis and results prediction, and optimising colloidal gold nanosensors for pathogen detection

 

Workplan & Expected Impact